rs121909603
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000574.5(CD55):c.261G>A(p.Trp87*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000574.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- protein-losing enteropathyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant has been reported as a Cromer blood group antigen (PMID: 7519480, 9675792), but has not been reported in individuals with CD55-related disease. This variant is also known as 314G>A and Trp53>Stop in the literature. ClinVar contains an entry for this variant (Variation ID: 16871). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp87*) in the CD55 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CD55 are known to be pathogenic (PMID: 28657829, 28657861). -
Cromer blood group system Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at